Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9

被引:2
|
作者
Han, Hyeong-jun [1 ,2 ]
Kim, Jung-Hyun [1 ,2 ]
机构
[1] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Cheongju 28160, South Korea
[2] Korea Inst Hlth, Natl Stem Cell Bank Korea, Cheongju 28160, South Korea
关键词
D O I
10.1016/j.scr.2021.102187
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The Toll-like receptor (TLR) family plays an important role in the recognition of pathogens, including bacteria, viruses, fungi, and parasites, followed by the activation of innate immunity. TLR3 recognizes double-stranded RNA, a form of genetic material produced by positive-strand RNA viruses and DNA viruses, and is activated by viral infection. Upon recognition, TLR3 promotes the activation of interferon regulatory factor 3 to enhance the expression and secretion of type I interferons that signal other cells to enhance their antiviral defenses. We generated biallelic mutants of the TLR3 gene using a CRISPR-Cas9 genome editing method in human induced pluripotent stem cells (hiPSCs). TLR3 homozygous-knockout hiPSCs retained normal morphology, gene expression, and in vivo differentiation potential.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Seo, Hyang-Hee
    Han, Hyo-Won
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2019, 40
  • [2] Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-Jun
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2021, 57
  • [3] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
    Yi, Tong
    Bai, Rui
    Sun, Hairui
    Lan, Feng
    Zhang, Hongjia
    He, Yihua
    STEM CELL RESEARCH, 2020, 47
  • [4] Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing
    Chen, Diyu
    Song, Bing
    Cheng, Yi
    Zhu, Lifen
    Lu, Dian
    Liu, Nengqing
    Yang, Yinghong
    Sun, Xiaofang
    STEM CELL RESEARCH, 2021, 55
  • [5] Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Han, Hyo-Won
    Seo, Hyang-Hee
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2019, 40
  • [6] Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9
    Chen, Shuhan
    Luo, Zhiwei
    Ward, Carl
    Ibanez, David P.
    Liu, Hao
    Zhong, Xiaofen
    Sharma, Narendra K.
    Qin, Baoming
    Fan, Wenxia
    Wang, Dongye
    STEM CELL RESEARCH, 2020, 45
  • [7] Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Maierhof, Smilla K.
    Schinke, Christian
    Cernoch, Janine
    Hew, Lois
    Bruske, Laura Pauline
    Vallone, Valeria Fernandez
    Fischer, Kristin
    Stachelscheid, Harald
    Huehnchen, Petra
    Endres, Matthias
    Diecke, Sebastian
    Telugu, Narasimha Swamy
    Boehmerle, Wolfgang
    STEM CELL RESEARCH, 2023, 73
  • [8] Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9
    Kim, So-Jung
    Habib, Omer
    Kim, Jin-Soo
    Han, Hyo-Won
    Koo, Soo Kyung
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2017, 19 : 46 - 48
  • [9] Establishment of a PPP2CA homozygous knockout human embryonic stem cell line via CRISPR/Cas9 system
    Ding, Tongbin
    Gao, Zhe
    Liu, Hang
    Li, Yuan
    Liu, Shichao
    Jian, Liguo
    STEM CELL RESEARCH, 2023, 67
  • [10] Establishment of a CIB1 knockout human pluripotent stem cell line via CRISPR/Cas9 genome editing technology
    Gong, Tingyu
    Liu, Dandan
    Wang, Xiaochen
    Zhou, Danni
    Tang, Ling
    Wang, Hao
    Su, Jun
    Liang, Ping
    STEM CELL RESEARCH, 2024, 81